Cancer Center - Froedtert Hospital
8800 West Doyne Ave.Milwaukee, WI, 53226
Dr. Deininger received his MD from the University of Würzburg Medical School, Germany and his PhD from Imperial College, London. His thesis work focused on signal transduction and the potential use of imatinib (Gleevec) as molecularly targeted therapy for chronic myeloid leukemia (CML), and contributed to the approval of imatinib for the treatment of CML. In 2002 he was recruited to the Divis… Read more ›
| University | Degree | Focus | Graduated |
|---|---|---|---|
| University of Wurzburg Medical School | Doctorate | Other | 1990 |
| Klinikum Nuernberg Nord, University of Erlangen/Nuernberg | Masters Degree | Other | 1995 |
| Imperial College London | Doctorate | Other | 1999 |
| University of Leipzig | Masters Degree | Other | 2002 |
| Institution | Focus | Year |
|---|---|---|
| Internship - Marienhospital | Other | 1992 |
Michael Deininger, MD, PhD has not yet indicated the hospitals that he is affiliated with.
Accepts New Patients: Yes